Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?
1998

Chromosome 9 Loss and Bladder Cancer Recurrence

Sample size: 53 publication Evidence: moderate

Author Information

Author(s): JMS Bartlett, AD Watters, SA Ballantyne, JJ Going, KM Grigor, TG Cooke

Primary Institution: Glasgow University Department of Surgery

Hypothesis

Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?

Conclusion

Loss of chromosome 9 in primary tumors is associated with a higher risk of recurrence in bladder cancer patients.

Supporting Evidence

  • Loss of chromosome 9 was detected in 36% of patients with subsequent disease recurrence.
  • Only 5% of non-recurrent patients showed loss of chromosome 9.
  • The study demonstrated that chromosome 9 loss occurs early in tumorigenesis.

Takeaway

If a patient has bladder cancer and loses a piece of chromosome 9, they might have a higher chance of their cancer coming back.

Methodology

Fluorescence in situ hybridization (FISH) was used to analyze chromosome 9 copy number in tumor samples from patients.

Limitations

The study focused only on superficial tumors and may not apply to more advanced stages.

Participant Demographics

The study included 53 patients with transitional cell carcinoma, with a male-to-female ratio of approximately 3:1.

Statistical Information

P-Value

0.0085

Statistical Significance

p=0.0085

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication